Patents matching “formulation”

US 6926909

Chrono delivery formulations and method of use thereof

Elite Laboratories, Inc. · Granted Aug 9, 2005 · Expires Aug 4, 2025

US 6896909

Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders

WINMEDICAL S.R.L. · Granted May 24, 2005 · Expires May 19, 2025

US 6846809

PEI: DNA vector formulations for in vitro and in vivo gene delivery

The Board of Regents of the University of Texas System · Granted Jan 25, 2005 · Expires Jan 20, 2025

US 6844004

Topical formulations of natamycin/pimaricin

The Board of Regents of the University of Texas System · Granted Jan 18, 2005 · Expires Jan 13, 2025

US 6713446

Formulation of boronic acid compounds

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 30, 2004 · Expires Mar 25, 2024

US 6699835

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 2, 2004 · Expires Feb 26, 2024

US 2004033243

SINCALIDE FORMULATIONS

BRACCO INT BV [NL] · Granted Feb 19, 2004 · Expires Feb 14, 2024

US 6676941

Antibody conjugate formulations for selectively inhibiting VEGF

The Board of Regents of the University of Texas System · Granted Jan 13, 2004 · Expires Jan 8, 2024

US 6589560

Stable glassy state powder formulations

Nektar Therapeutics · Granted Jul 8, 2003 · Expires Jul 3, 2023

US 6586573

Albumin-free Factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Jul 1, 2003 · Expires Jun 26, 2023

US 6569459

Method of administration of paclitaxel-plasma protein formulation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 27, 2003 · Expires May 22, 2023

US 6555127

Multi-spike release formulation for oral drug delivery

Pharmaceutical Discovery Corporation · Granted Apr 29, 2003 · Expires Apr 24, 2023

US 6482417

Stable pharmaceutical formulation comprising torsemide modification II

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 19, 2002 · Expires Nov 14, 2022

US 6410049

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery

The Regents of the University of California · Granted Jun 25, 2002 · Expires Jun 20, 2022

US 6399087

Propofol formulation with enhanced microbial inhibition

Amphastar Pharmaceuticals, Inc. · Granted Jun 4, 2002 · Expires May 30, 2022

US 6319904

Formulation comprising antibacterial substance and antiulcer substance

Takeda Chemical Industries Ltd. · Granted Nov 20, 2001 · Expires Nov 15, 2021

US 6306436

Stabilized, acid-free formulation for sustained release of bupropion hydrochloride

Teva Pharmaceuticals USA, Inc. · Granted Oct 23, 2001 · Expires Oct 18, 2021

US 6297286

Therapeutic use and formulation

Darwin Discovery Limited · Granted Oct 2, 2001 · Expires Sep 27, 2021

US 6284805

Plastics container containing stabilized drug formulation

Darwin Discovery Limited · Granted Sep 4, 2001 · Expires Aug 30, 2021

US 6242486

Long chain carboxybetaines in antimicrobial formulations

Integrated Research Technology, LLC · Granted Jun 5, 2001 · Expires May 31, 2021

AU 7286300

Dispersion formulations containing lipase inhibitors

CHEPLAPHARM ARZNEIMITTEL GMBH · Granted Apr 17, 2001 · Expires Apr 12, 2021

AU 7517700

Solid lipid formulations

CHEPLAPHARM ARZNEIMITTEL GMBH · Granted Apr 17, 2001 · Expires Apr 12, 2021

US 6200597

Formulation and use of carotenoids in treatment of cancer

The Board of Regents of the University of Texas System · Granted Mar 13, 2001 · Expires Mar 8, 2021

US 6077536

Pharmaceutical formulation

BEECHAM GROUP PLC [GB] · Granted Jun 20, 2000 · Expires Jun 15, 2020